Advances in the treatment of infantile cholestatic hepatopathy
10.3760/cma.j.issn.1673-4408.2021.12.010
- VernacularTitle:婴儿胆汁淤积性肝病的治疗进展
- Author:
Dongwei WANG
1
;
Jie WU
Author Information
1. 中国医科大学附属盛京医院小儿消化科，沈阳 110004
- Keywords:
Cholestatic hepatopathy;
Jaundice;
Therapy;
Infant
- From:
International Journal of Pediatrics
2021;48(12):838-842
- CountryChina
- Language:Chinese
-
Abstract:
Cholestatic hepatopathy is a hepatobiliary system disease caused by abnormal bile excretion.It is common in infants.And its incidence varies with region and cause.The incidence of cholestatic jaundice in full-term infants is about 1/2 500.The etiology of infantile cholestatic hepatopathy involves many factors including abnormal liver or bile ducts structure, genetic metabolic diseases, infections, endocrine diseases and parenteral nutrition-associated cholestasis.The disease needs to be treated according to the primary disease.If there is a clear etiology, etiological treatment is necessary.Usually symptomatic and comprehensive treatment is adopted due to inconclusive diagnosis.The artical mainly states the present therapy methods.
